Title	Publication Date	Language	Citations
Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting	2023/04/01	English	17
Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer	2018/06/01	English	17
Patient Experience of Systematic Versus Fusion Prostate Biopsies	2018/08/01	English	17
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness	2018/12/01	English	17
Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study	2019/05/01	English	17
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging	2022/02/01	English	17
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations	2022/08/01	English	17
Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men	2021/12/01	English	17
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy	2020/02/01	English	16
Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study	2020/10/01	English	16
Mortality Trends from Urologic Cancers in Europe over the Period 1980–2017 and a Projection to 2025	2021/10/01	English	16
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group	2020/08/01	English	16
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma	2018/10/01	English	16
Quality Assessment of Intraoperative Adverse Event Reporting During 29 227 Robotic Partial Nephrectomies: A Systematic Review and Cumulative Analysis	2020/12/01	English	16
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial	2021/06/01	English	16
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review	2021/10/01	English	16
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis	2020/04/01	English	16
The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy	2018/09/01	English	16
Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors	2019/02/01	English	16
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial	2022/04/01	English	16
Development and Internal Validation of a Nomogram for Predicting Renal Function after Partial Nephrectomy	2019/02/01	English	15
Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy	2018/06/01	English	15
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing	2021/12/01	English	15
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance	2021/04/01	English	15
Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer	2021/02/01	English	15
Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy	2021/02/01	English	15
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review	2022/04/01	English	15
Estimating Postoperative Renal Function After Surgery for Nonmetastatic Renal Masses: A Systematic Review of Available Prediction Models	2023/04/01	English	15
Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration	2019/02/01	English	15
Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodexyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study	2022/08/01	English	15